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Background:
Immune profile for influenza viruses is highly changeable over time. Serological studies can assess the prevalence of influenza, estimate the risk of infection, 
highlight asymptomatic infection rate and can also provide data on vaccine coverage. The aims of the study were to evaluate pre-existing cross-protection 
against influenza A(H3) drift viruses and to assess influenza immunity in the Portuguese population during 2014.
Conclusions:
There was a correlation between virus circulation, incidence rates for each age group and the previous seroprotection for seasonal influenza viruses and a
limited pre-existing cross-reactive antibodies to new drift A(H3) viruses. Our study emphasize the value of seroepidemiological studies to inform policy makers
on the need for vaccination and/or additional preventive measures.
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Methods:
Was developed a cross-sectional study based on a convenience sample of 626 sera collected during June 2014, covering all age groups, both gender and all 
administrative health regions of Portugal. Sera antibody titers for seasonal and new A(H3) drift influenza virus were evaluated by hemagglutination inhibition 
assay (HI). Seroprevalence to each seasonal influenza vaccine strain virus and to the new A(H3) drift circulating strain [A/Switzerland/9715293/2013 and
A/Hong Kong/5738/2014]  was estimated by age group, gender and region and compared with seasonal influenza-like illness (ILI) incidence rates before and 
after the study period.
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Seroprotection rates against seasonal influenza by hemagglutination 
inhibition assay (HI titer ≥ 40) and geometric means titer (GMT) in June 
2014 on Portuguese population. 
Viruses 
Estimation 
of p 
 HI ≥ 40 GMT 
 number/total % 95% CI value 95% CI 
AH1pdm09a   186/626 29.7 26.3 - 33.4  16.4 15.0 - 18.0 
AH3b   250/626 39.9 36.2 - 43.8  22.6 20.3 - 25.3 
B_Massc   144/626 23.0 19.9 - 26.5  13.6 12.6 - 14.7 
B_Brisbd   57/626 9.1 7.1 - 11.6  9.6 9.1 - 10.2 
 
p-value* 
 
 <0.001 
 
<0.001 
*p-value refers to the comparison of ratio of viruses (chi-square test), as well as to the 
comparison of virus titers (Kruskal-Wallis test). 
aA/California/7/2009; bA/Texas/50/2012; cB/Massachusetts/2/2012 (Yamagata lineage); 
dB/Brisbane/60/2008 (Victoria lineage). 
c Luís Milho, Ana Paula Coelho, Aida Fernandes, Paula Caseiro, Fernando Rodrigues, 
Lurdes Correia, João Pereira-Vaz, Sofia Almeida, Paula Branquinho, Rita Côrte-Real, 
Regina Viseu, Maria João Peres, Raquel Sanches, Filipa Dantas, Ludovina Freitas, 
Graça Andrade, Manuel Maurílio, Filomena Caldeira, Rita Cabral Veloso, 
Luisa Mota-Vieira, Marta Soares, Ana Rita Couto, Jácome Bruges-Armas, 
Rita Mouro Pinto, Joana Sobrinho Simões, Maria do Rosário Costa, 
João Tiago Guimarães, Luís Martins, Mário Cunha
A decreasing trend in seroprotection for influenza, from north to south of Portugal 
mainland was observed. The highest seroprevalence rate was observed in the 
north region to A(H3) (69.4%), and the lowest seroprevalence rate in Algarve to 
influenza B/Victoria lineage (2.6%).
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• Low pre-existing cross-protection against new A(H3) drift viruses.
• Seroprevalences for A(H3) and A(H1)pdm09 were higher than influenza B.
• Influenza A(H3) and A(H1)pdm09 seroprevalence was higher in children
and adults.
• Influenza B seroprevalence was higher in the elderly..
Protective antibodies titers against new drift A(H3) viruses [A/Hong
Kong/5738/2014 and A/Switzerland/9715293/2013] were found in 46% of
A/Texas/50/2012 seropositive individuals. Seroprotection was higher in age groups
under 15 and above 64.
